Assessing the pattern of recurrence in Danish stage I lung cancer patients in relation to the follow-up program: are we failing to identify patients with cerebral recurrence?

References

• Jakobsen E, Rasmussen TR, Green A. Mortality and survival of lung cancer in Denmark: results from the Danish Lung Cancer Group 2000–2012. Acta Oncol (Madr). 2016;55:2–8. DOI:10.3109/0284186X.2016.1150608.
   PubMed Web of Science ®Google Scholar
• Colt HG, Murgu SD, Korst RJ, et al. Follow-up and surveillance of the patient with diagnosis and management of lung cancer, 3rd ed: American College of. Chest Physicians. Chest. 2013;143:e437S–e454S. DOI:10.1378/chest.12-2365.
   PubMed Web of Science ®Google Scholar
• Helsedirektoratet. Nasjonalt Handlingsprogram med Retningslinjer for Diagnostikk, Behandling og Oppfølging av Lungekreft, Mesoteliom og Thymom [Internet]. Norway, Oslo, Helsedirektoratet. 2016 June. Norwegian. Available from: https://helsedirektoratet.no/r.
   Google Scholar
• Christensen NL, Jekunen A, Heinonen S, et al. Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison. Acta Oncol (Madr). 2017;56:943–948. DOI:10.1080/0284186X.2017.1315172.
   PubMed Web of Science ®Google Scholar
• Novello S, Barlesi F, Califano R, et al. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:V1–V27. DOI:10.1093/annonc/mdw326.
   PubMed Web of Science ®Google Scholar
• Robinson CG, Dewees TA, Naqa IME, et al. Patterns of failure after stereotactic body radiation therapy or Lobar Resection for. JTO Acquis. 2013;8:192–201. DOI:10.1097/JTO.0b013e31827ce361.
   Google Scholar
• Fedor D, Johnson WR, Singhal S. Local recurrence following lung cancer surgery: incidence, risk factors, and outcomes. Surg Oncol. 2013;22:156–161. DOI:10.1016/j.suronc.2013.04.002.
   PubMed Web of Science ®Google Scholar
• Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv1–iv21. DOI:10.1093/annonc/mdx222.
   PubMed Web of Science ®Google Scholar
• Sundhedsstyrrelsen. Kraeftpakkeforløb For Lungecancer [Internet]. Denmark, Copenhagen, Sundhedsstyrelsen; 2012 [Updated 2013 Jul 1]. Danish. Available From: http://sundhedsstyrelsen.dk/∼/media/30309E0576AF42CF95138AC3CE59CF74.ashx.
   Google Scholar
• Mirsadraee S. The 7th lung cancer TNM classification and staging system: review of the changes and implications. Wjr. 2012;4:0. DOI:10.4329/wjr.v4.i4.128.
   Google Scholar
• Jakobsen E, Green A, Oesterlind K, et al. Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry. J Thorac Oncol. 2013;8:1238–1247.
   PubMed Web of Science ®Google Scholar
• Calman L, Beaver K, Hind D, et al. Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis. J Thorac Oncol. 2011;6:1993–2004.
   PubMed Web of Science ®Google Scholar
• Ho C, Siegfried J, Remo K, et al. Adherence to surveillance guidelines in resected NSCLC: physician compliance and impact on outcomes. Lung Cancer. 2017;112:176–180. (June 2016):DOI:10.1016/j.lungcan.2017.08.012.
   PubMed Web of Science ®Google Scholar
• Schmidt-Hansen M, Baldwin DR, Hasler E. What is the most effective follow-up model for lung cancer patients? A systematic review. J Thorac Oncol. 2012;7:821–824. DOI:10.1097/JTO.0b013e31824afc55.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier INCT00198341, Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up. Available from: https://clinicaltrials.gov/ct2/show/NCT00198341?term=IFCT.
   Google Scholar
• Shimada Y, Saji H, Yoshida K, et al. Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer. Chest. 2013;143:1626–1634. DOI:10.1378/chest.12-1717.
   PubMed Web of Science ®Google Scholar
• Hochstenbag MMH, Twijnstra A, Hofman P, et al. MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? Lung Cancer. 2003;42:189–193. DOI:10.1016/S0169-5002(03)00291-5.
   PubMed Web of Science ®Google Scholar
• Fenske DC, Price GL, Hess LM, et al. Systematic review of brain metastases in patients with non-small-cell lung cancer in the United States, European Union, and Japan. Clin Lung Cancer. 2017;18:607–614. DOI:10.1016/j.cllc.2017.04.011.
   PubMed Web of Science ®Google Scholar
• Consonni D, Pierobon M, Gail MH, et al. Lung cancer prognosis before and after recurrence in a population-based setting. JNCI J Natl Cancer Inst. 2015;107:djv059. DOI:10.1093/jnci/djv059.
   Web of Science ®Google Scholar
• Niibe Y, Nishimura T, Inoue T, et al. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects. BMC Cancer. 2016;16:659. DOI:10.1186/s12885-016-2680-8.
   PubMed Web of Science ®Google Scholar
• Gourcerol D, Scherpereel A, Debeugny S, et al. Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer. Eur Respir J. 2013;42:1357–1364. DOI:10.1183/09031936.00086712.
   PubMed Web of Science ®Google Scholar
• Kanou T, Okami J, Tokunaga T, et al. Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer. Thorac Cancer. 2015;6:38–42. DOI:10.1111/1759-7714.12137.
   PubMed Web of Science ®Google Scholar
• Dawe DE, Greenspoon JN, Ellis PM. Brain metastases in non-small-cell lung cancer. Clin Lung Cancer. 2014;15:249–257. DOI:10.1016/j.cllc.2014.04.008.
   PubMed Web of Science ®Google Scholar
• Germain F, Wai ES, Berthelet E, et al. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy. Am J Clin Oncol. 2008;31:561–566. DOI:10.1097/COC.0b013e318172d5f9.
   PubMed Web of Science ®Google Scholar